Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC)

0.9556
Delayed Data
As of Apr 24
 +0.0106 / +1.12%
Today’s Change
0.51
Today|||52-Week Range
3.72
+36.53%
Year-to-Date
No recent news for Cyclacel Pharmaceuticals Inc.

Today’s Trading

Previous close0.95
Today’s open0.96
Day’s range0.93 - 0.98
Volume187,586
Average volume (3 months)1,156,922
Market cap$32.9M
Dividend yield--
Data as of 3:59pm ET, 04/24/2015

Growth & Valuation

Earnings growth (last year)+30.47%
Earnings growth (this year)-7.87%
Earnings growth (next 5 years)--
Revenue growth (last year)+59.96%
P/E ratioNM
Price/Sales8.86
Price/Book1.02

Competitors

 Today’s
change
Today’s
% change
SKBISkystar Bio-Pharmace...-0.02-0.52%
OGENOragenics Inc+0.00+0.26%
ACURAcura Pharmaceutical...-0.01-1.29%
ALXAAlexza Pharmaceutica...-0.06-3.00%
Data as of 4:00pm ET, 04/24/2015

Financials

Next reporting dateMay 11, 2015
EPS forecast (this quarter)-$0.25
Annual revenue (last year)$1.7M
Annual profit (last year)-$19.4M
Net profit margin-1,119.15%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Spiro Rombotis
COO, CFO, Secretary, Director &
Executive VP
Paul McBarron
Corporate headquarters
Berkeley Heights, New Jersey

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers